Paul is the Chief Executive Officer of Thorne Research, responsible for defining the strategic direction for Thorne’s various business segments, with primary emphasis on innovative business development. He has extensive experience in investment banking, finance, and fundraising.
Prior to his current role at Thorne, Paul was the Chief Executive Officer of Diversified Natural Products (DNP) and served as a director of Progenics Pharmaceuticals. He was a partner and co-head of the Liquid Capital Markets department of Goldman, Sachs & Co.
Paul received his MBA from Washington University in St. Louis, Missouri and his BA degree from Vanderbilt University.